Dr. Reddy’s gets positive CHMP opinion from EMA for its proposed Rituximab biosimilar
HYDERABAD, India – Dr. Reddy’s announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the launch of its proposed biosimilar Rituximab candidate DRL_RI (ITUXREDI) in European markets. Dr.